SIX Swiss Exchange · Healthcare
Invest in Sonova stock from India
Indian and foreign residents can buy Sonova (SOON) shares directly through Paasa.
By Paasa · Updated
Sonova at a glance
- Price
- CHF 255.40+CHF 3.00 (1.19%)
- Market cap
- CHF 15.17B
- Day range
- CHF 252.20 – CHF 257.00
- P/E
- 35.33
- Dividend yield
- 1.84%
- Volume
- 115.13K
- 1 month
- +10.47%
- 6 months
- +40.87%
- YTD
- +23.32%
- 1 year
- +14.12%
- 5 years
- -24.90%
Sonova statements, FY2022–FY2026
| Fiscal year | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | CHF 3.6B | CHF 3.6B | CHF 3.6B | CHF 3.7B | CHF 3.4B |
| Gross profit | CHF 2.7B | CHF 2.7B | CHF 2.6B | CHF 2.6B | CHF 2.5B |
| Operating income | CHF 675.8M | CHF 719.8M | CHF 669.9M | CHF 746.7M | CHF 760.0M |
| Net income | CHF 430.6M | CHF 540.5M | CHF 601.0M | CHF 647.5M | CHF 649.0M |
| Earnings per share | CHF 7.23 | CHF 9.07 | CHF 10.08 | CHF 10.75 | CHF 10.42 |
| EBITDA | CHF 965.1M | CHF 991.4M | CHF 960.4M | CHF 1.0B | CHF 995.7M |
| Total assets | CHF 5.6B | CHF 5.9B | CHF 5.8B | CHF 5.6B | CHF 5.6B |
| Total debt | CHF 1.7B | CHF 1.8B | CHF 1.8B | CHF 1.8B | CHF 1.5B |
| Cash and short-term investments | CHF 722.1M | CHF 687.1M | CHF 513.8M | CHF 414.8M | CHF 612.0M |
| Shareholders' equity | CHF 2.6B | CHF 2.7B | CHF 2.5B | CHF 2.2B | CHF 2.4B |
| Operating cash flow | CHF 684.1M | CHF 793.7M | CHF 753.3M | CHF 763.4M | CHF 922.5M |
| Free cash flow | CHF 602.7M | CHF 656.1M | CHF 624.7M | CHF 609.1M | CHF 815.9M |
| Capital expenditure | −CHF 81.4M | −CHF 137.6M | −CHF 128.6M | −CHF 154.3M | −CHF 106.6M |
Fiscal years as reported, the latest ending 31 Mar 2026. Figures in CHF; a dash means the provider reported nothing for that line.
Peer comparison
| Company | Ticker | Price | Market cap |
|---|---|---|---|
| Abbott Laboratories | ABT | $98.49 | $170.43B |
| Medtronic | MDT | $87.75 | $112.32B |
| Demant | DEMANT.CO | $321.40 | $67.78B |
| Koninklijke Philips | PHIA.AS | €21.48 | €21.00B |
| Cochlear | COH.AX | $129.00 | $8.44B |
Peers as grouped by the data provider. This is not an investment recommendation.
Analyst price targets
- Low
- —
- High
- —
- Median
- —
- Consensus
- —
Ratings: 0 buy · 0 hold · 1 sell. Consensus: Sell.
Published sell-side 12-month targets in CHF, aggregated by the data provider. They are not Paasa's view and not a forecast.
How to invest in Sonova from India
Step 1
Open your Paasa account
KYC takes a few minutes: PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Step 2
Add funds from your Indian bank account
Remit up to $250,000 a year under the RBI's Liberalised Remittance Scheme. Your bank converts the rupees to US dollars at its rate on the day you remit, and Interactive Brokers converts the dollars to CHF when you buy.
Step 3
Search SOON and buy
Find Sonova by name or by its ticker, SOON, and place your order.
Why invest in Sonova from India
What Sonova does
Headquartered in Stäfa, Switzerland, Sonova Holding AG is a leading provider of innovative hearing care solutions for both adults and children. The company's operations are divided into two primary segments: Hearing Instruments and Cochlear Implants. Sonova operates in the Medical - Devices industry within the Healthcare sector.
Paasa handles the paperwork
Investing abroad brings paperwork with it: remittance filings, capital gains reporting, foreign asset disclosure. Paasa prepares all of it for you. Your India-ready tax reports arrive at year end, ready to file.
Frequently asked questions
Can I buy Sonova stock from India?
Yes. Indian residents and NRIs can buy Sonova (SOON) shares directly through Paasa. Sonova is listed on the SIX Swiss Exchange, in the Medical - Devices industry. Your money leaves India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name at Interactive Brokers.
What tax do I pay in India when I sell Sonova shares?
In India, gains on shares held for more than 24 months are long-term and taxed at 12.5%, and gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. Both are worked out in rupees at the CHF/INR rate on the day you bought and the day you sold, so the currency move is part of the gain. Paasa's capital-gains statement gives you the figures for your return.